Table 5 Reporting of details on DMCs in trials that mentioned DMCs (n = 89)
Parameter | Pediatric Journals (n = 26) | General Journals (n = 63) |
|---|---|---|
Members Identity | Â | Â |
   Reported | 16 (62) | 51 (81) |
   Unclear or Not Reported | 10 (38) | 12 (19) |
Member Affiliations | Â | Â |
   Reported | 6 (23) | 19 (30) |
   Unclear or Not Reported | 20 (77) | 44 (70) |
Independence | Â | Â |
   Reported | 10 (39) | 23 (37) |
   Unclear or Not Reported | 16 (61) | 40 (63) |
Monitored outcomes | Â | Â |
   Reported | 11 (42) | 39 (62) |
   Unclear or Not Reported | 15 (58) | 24 (38) |
Vigilance of other trial conduct parameters | Â | Â |
   Reported | 5 (9) | 12 (19) |
   Unclear or Not Reported | 21 (81) | 51 (81) |
Blinding to Primary Outcome Data | Â | Â |
   Reported | 7 (27) | 18 (29) |
   Unclear or Not Reported | 19 (73) | 45 (71) |
Predefined Stopping Guidelines | Â | Â |
   Reported | 5 (19) | 18 (29) |
   Unclear or Not Reported | 21 (81) | 45 (71) |